Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.
3.

Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.

Bisogna M, Calvano JE, Ho GH, Orlow I, Cordón-Cardó C, Borgen PI, Van Zee KJ.

Cancer Genet Cytogenet. 2001 Mar;125(2):131-8.

PMID:
11369056
4.

Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.

Haviernik P, Schmidt M, Hu X, Wolff L.

Oncogene. 2003 Mar 20;22(11):1600-10.

PMID:
12642863
5.

Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines.

Zhou JN, Linder S.

Anticancer Res. 1996 Jul-Aug;16(4A):1931-5.

PMID:
8712723
6.

Rb independent inhibition of cell growth by p15(INK4B).

Aytac U, Konishi T, David H, Mendoza S, Miller CW.

Biochem Biophys Res Commun. 1999 Aug 27;262(2):534-8.

PMID:
10462509
8.

Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.

Schmidt M, Koller R, Haviernik P, Bies J, Maciag K, Wolff L.

Oncogene. 2001 Sep 27;20(43):6205-14.

10.

Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.

Chaussade L, Eymin B, Brambilla E, Gazzeri S.

Oncogene. 2001 Oct 4;20(45):6587-96.

11.

Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.

Roncalli M, Bianchi P, Bruni B, Laghi L, Destro A, Di Gioia S, Gennari L, Tommasini M, Malesci A, Coggi G.

Hepatology. 2002 Aug;36(2):427-32.

PMID:
12143052
12.

Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.

Peng B, Fleming JB, Breslin T, Grau AM, Fojioka S, Abbruzzese JL, Evans DB, Ayers D, Wathen K, Wu T, Robertson KD, Chiao PJ.

Clin Cancer Res. 2002 Nov;8(11):3628-38.

13.

Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.

Simon M, Köster G, Ludwig M, Mahlberg R, Rho S, Watzka M, Schramm J.

Acta Neuropathol. 2001 Aug;102(2):167-74.

PMID:
11563632
14.

The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas.

Ogino A, Yoshino A, Katayama Y, Watanabe T, Ota T, Komine C, Yokoyama T, Fukushima T.

J Neuropathol Exp Neurol. 2005 May;64(5):398-403.

15.

Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.

Ishiguro A, Takahata T, Saito M, Yoshiya G, Tamura Y, Sasaki M, Munakata A.

J Gastroenterol Hepatol. 2006 Aug;21(8):1334-9.

PMID:
16872319
16.

Identification and sequencing of the Syrian Golden hamster (Mesocricetus auratus) p16(INK4a) and p15(INK4b) cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells.

Muscarella P, Knobloch TJ, Ulrich AB, Casto BC, Moniaux N, Wittel UA, Melvin WS, Pour PM, Song H, Gold B, Batra SK, Weghorst CM.

Gene. 2001 Oct 31;278(1-2):235-43.

PMID:
11707341
17.

Expression of cyclin-dependent kinase inhibitor p15(INK4B) during normal and leukemic myeloid differentiation.

Teofili L, Morosetti R, Martini M, Urbano R, Putzulu R, Rutella S, Pierelli L, Leone G, Larocca LM.

Exp Hematol. 2000 May;28(5):519-26.

PMID:
10812241
18.

p15(INK4b) in HDAC inhibitor-induced growth arrest.

Hitomi T, Matsuzaki Y, Yokota T, Takaoka Y, Sakai T.

FEBS Lett. 2003 Nov 20;554(3):347-50.

19.

Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity.

Zong Z, Fujikawa-Yamamoto K, Tanino M, Teraoka K, Yamagishi H, Odashima S.

Biochem Biophys Res Commun. 1996 Feb 15;219(2):480-5.

PMID:
8605013
20.

Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.

Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K.

Int J Oncol. 2001 Aug;19(2):277-81.

PMID:
11445839
Items per page

Supplemental Content

Support Center